spacer gif spacer gif spacer gif spacer gif ARCHIVE ANNOUNCEMENT! spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 2


Fig. 2. SHP-2 regulates Spry phosphorylation. (A) FGF signaling pathway with Spry feedback loop. FGF activates Spry feedback by inducing spry expression (broken line) and stimulating tyrosine phosphorylation of Spry to generate Spry-P. Circled numbers indicate steps by which SHP-2/Csw could promote to increase signal output. (B) Effect of SHP-2 on Spry1 tyrosine phosphorylation. HEK293 cells were transfected with expression constructs for HA-Spry1, FGFR1c and either empty vector or expression constructs for dominant-negative SHP-2C459S or wild-type SHP-2 as indicated. Transfected cells were left untreated (lanes 1-3) or treated with bFGF (lanes 4-6). (Top) Immunoprecipitated HA-Spry1 analyzed on immunoblot with anti-phosphotyrosine antiserum. SHP-2C459S increased HA-Spry1 phosphorylation (lane 5) and SHP-2 reduced it (lane 6). (Middle) Immunoblot reprobed with anti-HA to show total HA-Spry1. (Bottom) Immunoblot of whole cell lysates probed with anti-SHP-2. Similar results were obtained in two experiments. (C) Specificity of phospho-specific Spry1 antiserum. HEK293 cells were transfected with expression plasmids for FGFR1c and HA-Spry1 or HA-Spry1Y53F as indicated. Transfected cells were treated with bFGF for times indicated, and HA-Spry1 was immunoprecipitated and analyzed on immunoblots probed with {alpha}-pY53 antiserum (top) or anti-HA to show total HA-Spry1 (bottom). (D) Effect of SHP-2C459S on Spry1 Y53 phosphorylation. HEK293 cells were transfected with plasmids expressing FGFR1c and HA-Spry1, and empty vector or vector expressing dominant-negative SHP-2C459S as indicated. Transfected cells were left untreated (lanes 1,2) or treated with bFGF for 60 minutes (lanes 3,4). (Top) Immunoblot of immunoprecipitated HA-Spry1 probed with {alpha}-pY53. SHP-2C459S increased phosphorylation on pY53. (Middle) Control immunoblot probed with anti-HA. (Bottom) Immunoblot of whole cell lysates probed with anti-SHP-2. Similar results were obtained in two experiments. (E) Effect of SHP-2C459S on other Spry1 phosphotyrosines. HEK293 cells were transfected with plasmids expressing FGFR1c and either empty vector or vector expressing dominant-negative SHP-2C459S as indicated, and plasmids expressing HA-Spry1 (WT, lanes 1,2), HA-Spry1Y53F (lanes 3, 4), HA-Spry1Y89F (lanes 5, 6), or HA-Spry1Y53F, Y89F (lanes 7, 8). FGF treatment and subsequent analysis with anti-phosphotyrosine antiserum was as in lanes 4 and 5 (of B). SHP-2C459S influenced tyrosine phosphorylation on HA-Spry1 when Y53 was altered (lanes 3,4), indicating that SHP-2 also affects other tyrosine(s), notably Y89 (lanes 5-8). Similar results were obtained in three experiments.





Right arrow Return to article